However, the innovation of this study lies in its incorporation of new perspectives on the pathogenesis of DKD and the evaluation of the role of SGLT2 inhibitors from the perspective of early renal tubular injury. The gene discussed is SLC5A2; the disease is diabetic kidney disease.